BAG3 Modulation for Caspase Inhibition and Mitochondrial Stability
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
The role of BAG3 in cardiac biology and its impact on inflammation and apoptosis is not fully understood, particularly in conditions of haploinsufficiency, leading to unregulated caspase activation and mitochondrial dysfunction, which contributes to various inflammatory diseases.
Innovation Solution
Administering a therapeutically effective amount of BAG3 encoding nucleic acid, protein, or peptide to modulate BAG3 expression and activity, thereby reducing caspase activation and inflammation through direct interaction with proteins like cIAP1/2 and TOM22, and regulating mitochondrial function.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Reliability
If BAG3 is deleted or reduced (haploinsufficiency), then certain diseases are prevented, but unregulated caspase activation and mitochondrial dysfunction occur leading to inflammation
Solution Approach 1:
The patent introduces an intermediary substance that binds to and stabilizes cIAP1/2 proteins, preventing their degradation and thereby inhibiting caspase activation. This intermediary acts as a mediator between BAG3 deficiency and the harmful inflammatory response, providing a therapeutic mechanism that addresses the contradiction between preventing disease and avoiding caspase activation.
Solution Approach 2:
The patent modifies the stability parameter of cIAP1/2 proteins by introducing a stabilizing agent that changes their degradation rate. By altering this parameter, the system prevents unregulated caspase activation while maintaining the benefits of BAG3 reduction, thus resolving the contradiction between disease prevention and inflammation control.
2Reliability
If BAG3 is over-expressed, then chemotherapy resistance and metastasis increase, but the full scope of BAG3's role in health and disease is not defined
Solution Approach 1:
The patent extracts and focuses on a specific functional aspect of BAG3 - its interaction with cIAP1/2 and TOM22 proteins - to understand its role in apoptosis and inflammation. By isolating this specific mechanism, the patent begins to define the full scope of BAG3's function without being overwhelmed by its multifunctionality, thereby addressing both the reliability issue and the knowledge gap.
3Object-generated harmful factors
If BAG3 interacts with cIAP1/2 and TOM22, then caspase activation is inhibited, but the mechanism is not fully understood
Solution Approach 1:
The patent segments the complex mechanism into distinct components: BAG3 interaction with cIAP1/2, stabilization of these proteins, inhibition of caspase activation, and maintenance of mitochondrial integrity. By dividing the mechanism into these discrete segments, the patent makes the overall process more understandable and actionable, resolving the contradiction between inhibiting caspase activation and understanding the mechanism.
Data Source
AI summary
Bag3 is a multifunctional protein expressed predominantly in the heart, the skeletal muscle, the central nervous system and in many cancers. Although BAG3 was cloned only a decade ago, studies have shown that genetic variants, particularly those that result in haplo-insufficiency, can lead to severe left ventricular dysfunction; however, the full mechanisms responsible have remained obscure. To obviate the influence of heart failure itself on the biology of Bag3, transgenic mice harboring a single allele knock-out were studied between 8 and 10 weeks of age before any obvious signs of heart failure were evident. The results were surprising and informative. First, it was found that despite a normal phenotype, young Bag3+/â had marked changes in the proteome that were characterized by changes in proteins associated with metabolism and apoptosis. Consistent with this finding, a decrease in the levels of critical proteins charged with maintaining the mitochondrial membrane potential was observed. It was also found that young mice shifted from a balance between the extrinsic and intrinsic pathways of apoptosis. However, in the presence of stress and the absence of Bag3 there was a shift from a balanced to an extrinsic dominant system (cleaved caspase 8). The diverse array of critical pathways regulated by Bag3 suggests a more important role especially during stress and that this role might include serving as an intracellular glue that holds proteins where they can be most effective rather than having them meet accidentally.